Study design and participants
Patient samples used in this study come from participants enrolled to the original ‘Naproxen Study’. Participants provided written informed consent to participate in the study, and ethical approval was obtained from the Institutional Review Boards (IRB) of all participating centers (IRB MDACC 2013-0698 and PA12-0327). Details on the trial design and participant demographics have been already reported (